SMITHKLINE'S FAILURE TO FORWARD SELACRYN REPORTS TO FDA FROM FRENCH DRUG DEVELOPER ANPHAR IS BASIS OF JUSTICE DEPT.'s 34 CHARGES AGAINST THE FIRM

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".